Breaking News

IDT Biologika Wins BARDA Contract

To provide fill finish services to support the development of live/vectored virus product candidates

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

The Biomedical Advanced Research and Development Authority (BARDA) within the office of the Assistant for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) has awarded IDT Biologika an Indefinite Quantity, Indefinite Delivery (IDIQ) contract to provide live virus filling and finishing services with an initial commitment of $100,000, subject to task order(s) for a maximum of $50 million.   BARDA seeks to establish fill/finish capabilities for use of live...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters